EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic value of a composite physiologic index developed by adding bronchial and hyperlucent volumes quantified via artificial intelligence technology

Michihiro Uyama, Tomohiro Handa, Ryuji Uozumi, Seishu Hashimoto, Yoshio Taguchi, Kohei Ikezoe, Kiminobu Tanizawa, Naoya Tanabe, Tsuyoshi Oguma, Atsushi Matsunashi, Takafumi Niwamoto, Hiroshi Shima und 10 weitere

Respiratory Research · 2024

DOI: 10.1186/s12931-024-03075-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiratory Research, 2024. Verfasst von Michihiro Uyama und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Artificial Intelligence, Bronchi, Tomography, X-Ray Computed. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science KAKENHI, Japan Agency for Medical Research and Development, Research Program on Rare and Intractable Diseases, Ministry of Health, Labor, Welfare of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The composite physiologic index (CPI) was developed to estimate the extent of interstitial lung disease (ILD) in idiopathic pulmonary fibrosis (IPF) patients based on pulmonary function tests (PFTs). The CALIPER-revised version of the CPI (CALIPER-CPI) was also developed to estimate the volume fraction of ILD measured by CALIPER, an automated quantitative CT postprocessing software. Recently, artificial intelligence-based quantitative CT image analysis software (AIQCT), which can be used to quantify the bronchial volume separately from the ILD volume, was developed and validated in IPF. The aim of this study was to develop AIQCT-derived CPI formulas to quantify CT abnormalities in IPF and to investigate the associations of these CPI formulas with survival. METHODS: The first cohort included 116 patients with IPF. In this cohort, ILD, bronchial, and hyperlucent volumes on CT were quantified using AIQCT. New CPI formulas were developed based on PFTs to estimate the volume fraction of ILD (ILD-CPI), the sum of the ILD and bronchial volume fractions (ILDB-CPI), and the sum of the ILD, bronchial and hyperlucent volume fractions (ILDBH-CPI). The associations of the original CPI, the CALIPER-CPI and the AIQCT-derived CPIs with survival were analyzed in the first cohort and in a second cohort of patients with IPF (n = 72). RESULTS: In the first cohort, over a median observation time of 92.8 months, 79 patients (68.1%) died, and one patient (0.9%) underwent living-donor lung transplantation. The original CPI, the CALIPER-CPI, and all AIQCT-derived CPIs were associated with overall survival (hazard ratios: 1.07-1.22). The C-index of the ILDB-CPI (0.759) was the highest among all AIQCT-derived CPIs and was comparable to that of the original CPI (0.765) and the CALIPER-CPI (0.749). The C-index of the ILDBH-CPI (0.729) was lower than that of the other CPI variables. The second cohort yielded similar C-indices as the first cohort for the original CPI (0.738), CALIPER-CPI (0.757) and ILDB-CPI (0.749). CONCLUSIONS: The ILDB-CPI can predict the outcomes of IPF patients with a similar performance to that of the original CPI and the CALIPER-CPI. Adding the hyperlucent volume to the CPI formula did not improve its predictive accuracy for mortality. TRIAL REGISTRATION: None (no health care interventions were performed).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceBronchiTomography, X-Ray ComputedHumansFemaleMaleAgedMiddle AgedPrognosisRespiratory Function TestsCohort StudiesRetrospective StudiesIdiopathic Pulmonary FibrosisLung Diseases, Interstitial

Stichwörter der Autor:innen

Artificial intelligence-based quantitative computed tomographic image analysis…Bronchial volumeComposite physiologic indexHyperlucent volumeIdiopathic pulmonary fibrosisInterstitial lung disease

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. hanta@kuhp.kyoto-u.ac.jp.
  • Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. hanta@kuhp.kyoto-u.ac.jp.
  • Department of Industrial Engineering and Economics, Tokyo Institute of Technology, Tokyo, Japan.
  • Department of Respiratory Medicine, Tenri Hospital, Tenri, Japan.
  • Department of Respiratory Medicine, Kyoto City Hospital, Kyoto, Japan.

Förderung

  • Japan Society for the Promotion of Science KAKENHI
  • Japan Agency for Medical Research and Development
  • Research Program on Rare and Intractable Diseases, Ministry of Health, Labor, Welfare of Japan
  • Ms. Mieko Sonoda Memorial Research Fund for Interstitial Lung Diseases
  • Kyoto Health Management Research Foundation

Zitieren

APA

Uyama, M., Handa, T., Uozumi, R., Hashimoto, S., Taguchi, Y., Ikezoe, K., Tanizawa, K., Tanabe, N., Oguma, T., Matsunashi, A., Niwamoto, T., Shima, H., Mori, R., Maetani, T., Shiraishi, Y., Nobashi, T. W., Sakamoto, R., Kubo, T., Yoshizawa, A., …, & Hirai, T. (2024). Prognostic value of a composite physiologic index developed by adding bronchial and hyperlucent volumes quantified via artificial intelligence technology. Respiratory Research. https://doi.org/10.1186/s12931-024-03075-8

Vancouver

Uyama M, Handa T, Uozumi R, Hashimoto S, Taguchi Y, Ikezoe K, et al. Prognostic value of a composite physiologic index developed by adding bronchial and hyperlucent volumes quantified via artificial intelligence technology. Respiratory Research. 2024. doi:10.1186/s12931-024-03075-8

BibTeX
@article{Uyama2024,
  author = {Uyama, Michihiro and Handa, Tomohiro and Uozumi, Ryuji and Hashimoto, Seishu and Taguchi, Yoshio and Ikezoe, Kohei and Tanizawa, Kiminobu and Tanabe, Naoya and Oguma, Tsuyoshi and Matsunashi, Atsushi and Niwamoto, Takafumi and Shima, Hiroshi and Mori, Ryobu and Maetani, Tomoki and Shiraishi, Yusuke and Nobashi, Tomomi W and Sakamoto, Ryo and Kubo, Takeshi and Yoshizawa, Akihiko and Terada, Kazuhiro and Nakamoto, Yuji and Hirai, Toyohiro},
  title = {Prognostic value of a composite physiologic index developed by adding bronchial and hyperlucent volumes quantified via artificial intelligence technology},
  journal = {Respiratory Research},
  year = {2024},
  doi = {10.1186/s12931-024-03075-8}
}
Kostenlos starten →